Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site


Click on country-registry for comparison

Flag Country Registry Registration periodNo. of cases included Complete FUIncomplete FU: loss to FU% with Complete FU at 5 yearsMedian FU (in months)
Alive/deadAt end of FUNo.%% lost to FU: years from diagnosis
No.%<11-33-5>5
China - Shangai1992-19953737100.000.00.00.00.00.0100.011.8
India - Barshi1993-2000807998.811.30.00.01.30.098.87.5
India - Chennai1990-1999101789287.712512.39.00.70.32.390.08.7
India - Karunagappally1991-1997333193.926.16.10.00.00.093.912.6
India - Mumbai1992-19941902162185.228114.89.30.20.35.090.28.3
Thailand - Chiang Mai1993-1997695478.31521.78.74.32.95.884.18.6
Thailand - Lampang1990-20004343100.000.00.00.00.00.0100.015.7
Thailand - Songkhla1990-19991298767.44232.613.27.06.26.273.613.2



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period